Jane Street
JBIO

Jane Street’s Jade Biosciences JBIO Stock Holding History

Jane Street’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-315
Closed -$27.6K – 9591
2025
Q1 		$27.6K Buy
+315
New +$27.7K ﹤0.01% 9103
2024
Q4 		– Sell
-509
Closed -$37.2K – 9364
2024
Q3 		$37.2K Sell
509
-2,641
-84% -$170K ﹤0.01% 9213
2024
Q2 		$183K Buy
3,150
+2,828
+878% +$1.88M ﹤0.01% 8457
2024
Q1 		$333K Sell
322
-52
-14% -$39.7K ﹤0.01% 7392
2023
Q4 		$297K Buy
+374
New +$191K ﹤0.01% 7613
2022
Q3 		– Sell
-335
Closed -$183K – 9673
2022
Q2 		$183K Buy
+335
New +$160K ﹤0.01% 8256
2022
Q1 		– Sell
-355
Closed -$146K – 10258
2021
Q4 		$146K Buy
+355
New +$180K ﹤0.01% 9018

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return